title: Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
authors.affiliation: NIH Clinical Center, National Institute of Health, Bethesda, MD, USA.
authors.forename: John
authors.initials: J
authors.lastname: Beigel
authors.forename: Katrin S
authors.initials: KS
authors.lastname: Kohl
authors.forename: Floyd
authors.initials: F
authors.lastname: Brinley
authors.forename: Philip L
authors.initials: PL
authors.lastname: Graham
authors.forename: Najwa
authors.initials: N
authors.lastname: Khuri-Bulos
authors.forename: Philip S
authors.initials: PS
authors.lastname: LaRussa
authors.forename: Patricia
authors.initials: P
authors.lastname: Nell
authors.forename: Scott
authors.initials: S
authors.lastname: Norton
authors.forename: Gillian
authors.initials: G
authors.lastname: Stoltman
authors.forename: Amina
authors.initials: A
authors.lastname: Tebaa
authors.forename: Karen
authors.initials: K
authors.lastname: Warschaw
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D003625:Data Collection / Q000706:statistics & numerical data*; D003627:Data Interpretation, Statistical; D007114:Immunization; D012449:Safety; D012900:Smallpox Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D009626:Terminology as Topic; D014615:Vaccinia / Q000209:etiology* / Q000503:physiopathology; D014616:Vaccinia virus
chemical_list: D012900:Smallpox Vaccine